UTAH MEDICAL PRODUCTS, INC. Cost of Revenue
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Cost of Revenue of $3.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-12
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $3.77M, a 13.47% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $3.44M, a 17.55% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $3.78M, a 1.41% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $4.21M, a 0.12% increase year-over-year.
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for fiscal 2025 was $16.52M, a 1.44% decline from fiscal 2024.
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for fiscal 2024 was $16.76M, a 16.97% decline from fiscal 2023.
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for fiscal 2023 was $20.19M, a 0.50% increase from fiscal 2022.
- UTAH MEDICAL PRODUCTS, INC. cost of goods and services sold for fiscal 2022 was $20.09M, a 10.74% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.77M 10-Q · filed 2026-08-12 | $7.21M 10-Q · filed 2026-08-12 | $10.99M derived: sum of 3 quarters · filed 2026-08-12 | $15.20M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $3.44M 10-Q · filed 2026-05-12 | $7.22M derived: sum of 2 quarters · filed 2026-05-12 | $11.43M derived: sum of 3 quarters · filed 2026-05-12 | $15.79M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $7.99M derived: sum of 2 quarters · filed 2026-03-27 | $12.35M derived: sum of 3 quarters · filed 2026-08-12 | $16.52M 10-K · filed 2026-03-27 |
| 2025-09-30 | $4.21M 10-Q · filed 2025-11-14 | $8.57M derived: sum of 2 quarters · filed 2026-08-12 | $12.74M 10-Q · filed 2025-11-14 | $16.57M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $4.36M 10-Q · filed 2026-08-12 | $8.53M 10-Q · filed 2026-08-12 | $12.37M derived: sum of 3 quarters · filed 2026-08-12 | $16.57M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $4.17M 10-Q · filed 2026-05-12 | $8.01M derived: sum of 2 quarters · filed 2026-05-12 | $12.21M derived: sum of 3 quarters · filed 2026-05-12 | $16.36M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $8.04M derived: sum of 2 quarters · filed 2026-03-27 | $12.19M derived: sum of 3 quarters · filed 2026-03-27 | $16.76M 10-K · filed 2026-03-27 |
| 2024-09-30 | $4.20M 10-Q · filed 2025-11-14 | $8.35M derived: sum of 2 quarters · filed 2025-11-14 | $12.93M 10-Q · filed 2025-11-14 | $18.16M derived: sum of 4 quarters · filed 2026-03-27 |
| 2024-06-30 | $4.15M 10-Q · filed 2025-08-12 | $8.72M 10-Q · filed 2025-08-12 | $13.96M derived: sum of 3 quarters · filed 2026-03-27 | $19.10M derived: sum of 4 quarters · filed 2026-03-27 |
| 2024-03-31 | $4.57M 10-Q · filed 2025-05-15 | $9.81M derived: sum of 2 quarters · filed 2026-03-27 | $14.96M derived: sum of 3 quarters · filed 2026-03-27 | $20.08M derived: sum of 4 quarters · filed 2026-03-27 |
| 2023-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $10.38M derived: sum of 2 quarters · filed 2026-03-27 | $15.51M derived: sum of 3 quarters · filed 2026-03-27 | $20.19M 10-K · filed 2026-03-27 |
| 2023-09-30 | $5.15M 10-Q · filed 2024-11-12 | $10.27M derived: sum of 2 quarters · filed 2024-11-12 | $14.95M 10-Q · filed 2024-11-12 | $20.20M derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-06-30 | $5.13M 10-Q · filed 2024-08-09 | $9.80M 10-Q · filed 2024-08-09 | $15.05M derived: sum of 3 quarters · filed 2025-03-26 | $19.82M derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-03-31 | $4.68M 10-Q · filed 2024-05-10 | $9.92M derived: sum of 2 quarters · filed 2025-03-26 | $14.69M derived: sum of 3 quarters · filed 2025-03-26 | $19.97M derived: sum of 4 quarters · filed 2025-03-26 |
| 2022-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $10.02M derived: sum of 2 quarters · filed 2025-03-26 | $15.29M derived: sum of 3 quarters · filed 2025-03-26 | $20.09M 10-K · filed 2025-03-26 |
| 2022-09-30 | $4.77M 10-Q · filed 2023-11-13 | $10.05M derived: sum of 2 quarters · filed 2023-11-13 | $14.84M 10-Q · filed 2023-11-13 | $19.64M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | $5.28M 10-Q · filed 2023-08-11 | $10.07M 10-Q · filed 2023-08-11 | $14.87M derived: sum of 3 quarters · filed 2024-03-26 | $19.37M derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | $4.79M 10-Q · filed 2023-05-05 | $9.59M derived: sum of 2 quarters · filed 2024-03-26 | $14.09M derived: sum of 3 quarters · filed 2024-03-26 | $18.91M derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $9.30M derived: sum of 2 quarters · filed 2024-03-26 | $14.12M derived: sum of 3 quarters · filed 2024-03-26 | $18.14M 10-K · filed 2024-03-26 |
| 2021-09-30 | $4.50M 10-Q · filed 2022-11-10 | $9.32M derived: sum of 2 quarters · filed 2022-11-10 | $13.34M 10-Q · filed 2022-11-10 | $18.08M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $4.82M 10-Q · filed 2022-08-12 | $8.84M 10-Q · filed 2022-08-12 | $13.58M derived: sum of 3 quarters · filed 2023-03-28 | $17.56M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $4.02M 10-Q · filed 2022-05-11 | $8.76M derived: sum of 2 quarters · filed 2023-03-28 | $12.74M derived: sum of 3 quarters · filed 2023-03-28 | $16.58M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $4.75M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | $8.73M derived: sum of 2 quarters · filed 2023-03-28 | $12.56M derived: sum of 3 quarters · filed 2023-03-28 | $16.63M 10-K/A · filed 2023-03-28 |
| 2020-09-30 | $3.98M 10-Q · filed 2021-11-12 | $7.82M derived: sum of 2 quarters · filed 2021-11-12 | $11.88M 10-Q · filed 2021-11-12 | $15.90M derived: sum of 4 quarters · filed 2022-03-25 |
| 2020-06-30 | $3.84M 10-Q · filed 2021-08-06 | $7.90M 10-Q · filed 2021-08-06 | $11.92M derived: sum of 3 quarters · filed 2022-03-25 | $17.04M derived: sum of 4 quarters · filed 2022-03-25 |
| 2020-03-31 | $4.07M 10-Q · filed 2021-05-11 | $8.08M derived: sum of 2 quarters · filed 2022-03-25 | $13.20M derived: sum of 3 quarters · filed 2022-03-25 | $17.54M derived: sum of 4 quarters · filed 2022-03-25 |
| 2019-12-31 | $4.02M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-25 | $9.13M derived: sum of 2 quarters · filed 2022-03-25 | $13.48M derived: sum of 3 quarters · filed 2022-03-25 | $17.44M 10-K · filed 2022-03-25 |
| 2019-09-30 | $5.12M 10-Q/A · filed 2020-11-09 | $9.46M derived: sum of 2 quarters · filed 2020-11-09 | $13.42M 10-Q/A · filed 2020-11-09 | $17.07M derived: sum of 4 quarters · filed 2021-03-26 |
| 2019-06-30 | $4.35M 10-Q · filed 2020-08-07 | $8.31M 10-Q · filed 2020-08-07 | $11.96M derived: sum of 3 quarters · filed 2021-03-26 | $16.05M derived: sum of 4 quarters · filed 2021-03-26 |
| 2019-03-31 | $3.96M 10-Q · filed 2020-05-08 | $7.61M derived: sum of 2 quarters · filed 2021-03-26 | $11.71M derived: sum of 3 quarters · filed 2021-03-26 | $15.69M derived: sum of 4 quarters · filed 2021-03-26 |
| 2018-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $7.75M derived: sum of 2 quarters · filed 2021-03-26 | $11.73M derived: sum of 3 quarters · filed 2021-03-26 | $15.69M 10-K · filed 2021-03-26 |
| 2018-09-30 | $4.10M 10-Q · filed 2019-11-07 | $8.08M derived: sum of 2 quarters · filed 2019-11-07 | $12.04M 10-Q · filed 2019-11-07 | $15.77M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $3.98M 10-Q · filed 2019-08-09 | $7.95M 10-Q · filed 2019-08-09 | $11.68M derived: sum of 3 quarters · filed 2020-03-16 | $15.31M derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $3.96M 10-Q · filed 2019-05-09 | $7.70M derived: sum of 2 quarters · filed 2020-03-16 | $11.32M derived: sum of 3 quarters · filed 2020-03-16 | |
| 2017-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $7.36M derived: sum of 2 quarters · filed 2020-03-16 | $15.02M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $3.63M 10-Q · filed 2018-11-07 | $11.29M 10-Q · filed 2018-11-07 | ||
| 2016-12-31 | $15.61M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |